New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
07:10 EDTALKSAlkermes reports Q1 EPS 11c, consensus 10c
Reports Q1 revenue $130.2M, consensus $135.79M
News For ALKS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 1, 2015
10:04 EDTALKSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:25 EDTALKSOn The Fly: Pre-market Movers
Subscribe for More Information
07:11 EDTALKSMorgan Stanley ups Alkermes two notches with $85 price target
Subscribe for More Information
06:46 EDTALKSAlkermes upgraded to Overweight from Underweight at Morgan Stanley
Subscribe for More Information
August 24, 2015
08:11 EDTALKSAlkermes delay for Aristada due to administrative issues, says Jefferies
Jefferies said it appears that the FDA's delay in approving Alkermes' Aristada is due to the agency's need for some additional review time. The firm said the fact that the FDA did not choose to issue a CRL letter gives it confidence that Alkermes should receive full approval in a "few weeks" and it maintains its Buy rating and $76 price target on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use